Senior executive with extensive experience in management functions as CFO and CEO. Specializes in sustainable value creation, driving development through purpose and values-based leadership. Skilled in aligning motivated and competent individuals with lean processes and efficient infrastructures to deliver high-quality, innovative, customer-oriented solutions while balancing diverse stakeholder interests. Thrives in challenging environments, excelling in strategic and operational planning with a focus on execution to consistently achieve outstanding results. Experienced in integrating small companies into larger business units, launching international business units, and developing global business. Cultivates a hands-on managerial culture rooted in entrepreneurship, partnership, rigor, discipline, knowledge sharing, and cooperation - always striving for best practices and excellence.
Achieved company growth by implementing strategic plans and streamlining operations:
· Implementation of a new governance system to sustain the transition from a familiar to a professional management model, preserving cultural traits, group core values, and identity.
· Implementation of a standard management model for Quilaban and Group companies, sustained by a Strategic, Tactical, and Operational Plan and a balanced scorecard model, to follow up on execution and align the organization.
· Led successful turnaround efforts for underperforming divisions or subsidiaries, restoring performance and profitability.
· Integration of new business streams with innovative value propositions, replacing old, non-sustainable, non-profitable businesses, reaching a combined average annual business growth above 10%.
· Construction of an international business network, made by associated companies in India, Mozambique, Angola, Guinea-Bissau, and partnerships for business development covering more than 20 countries.
Secured advantageous partnerships and collaborations to co-develop cutting-edge technologies and solutions:
· Genomics business launched in 2020, through a partnership with Illumina, reached €10M in 4 years, representing 25% of the Group's turnover, and positioned Quilaban as a leader in Genomics in the Portuguese Market.
· Trustful and transparent business relationships led to an enhanced portfolio of +40 representations
· Creation of a broad portfolio of successful partnerships with leading multinational companies in diagnostics, genetic sequencing, medicines, and healthcare devices.
· “Quilaban Academy” initiative drives the share of state-of-the-art knowledge from scientists to professionals who apply the innovations in the field.
Enhanced brand reputation with effective marketing campaigns and public relations efforts:
· Publication of an annual integrated report, presenting a triple bottom-line performance since 2024.
· Wide coverage of Quilaban's initiatives and awards on social media.
· Effective management of crisis during COVID, protecting Quilaban's reputation.
Created a positive work culture, increasing employee attraction, satisfaction, and retention rates:
· Best Place to Work certification.
· #1 in the 2024 People Engagement Survey in the sector of Health and Pharmaceutical
· Top 20 Happiness Works Company.
· “Educar para o Futuro” program, to support kids' Education, impacting +90 children.
· Implementation of the "Mood Sensor" tool to monitor people's mood and promote team' cohesion and mutual support.
Ensured compliance with regulatory and best practices by developing robust policies and procedures:
· Successful certification under ISO 9001 and ISO 14001. ISO 45001 in progress.
· Committed to Sustainable Development Goals, through participation in the United Nations Global Compact Portugal since 2020.
Founded a performance-and-merit based evaluation system to assess staff performance:
· Implementation of “Modelo de Impacto Funcional,” a tool connecting purpose to action, giving meaning to employees' actions, and measuring impact and performance.
Revitalized company's image and online presence, launching user-friendly website and engaging social media platforms:
· Rebranding Quilaban and creation of a Group Brand – Augma Group - launching a new communication strategy through the company website, annual report, and several internal and external communication instruments.
+13.000 followers in LinkedIn.